Gilead Sciences

Overview

Gilead Sciences, Inc. is a prominent American biopharmaceutical company based in Foster City, California. Founded in 1987 by Michael L. Riordan, it specializes in the research, development, and marketing of antiviral drugs for serious viral diseases, including HIV/AIDS, hepatitis B and C, influenza, and COVID-19. The company went public in 1992 and operates in over 20 countries.

The organization offers a diverse range of antiviral medications such as Viread and Truvada for HIV, ledipasvir/sofosbuvir for hepatitis C, and Tamiflu for influenza. Through the acquisition of Kite Pharma in 2017, it has expanded into cell therapy, focusing on cancer treatment. Gilead is dedicated to addressing public health challenges with initiatives like the COMPASS Initiative®, which targets the HIV epidemic in the Southern U.S. and supports affected communities.

Basic Information

Contact Details

• Phone: +1 650-574-3000
• Website: gilead.com
• LinkedIn: linkedin.com/company/gilead-sciences

Key Focus Areas & Initiatives

• Enterprise software
• Big data
• Cloud computing
• Recruiting
• Software
• Information technology
• Biotechnology: biological products (no diagnostic substances)
• Health care
• Biotechnology research
• Drug innovation
• Pharmaceutical and medicine manufacturing
• Corporate responsibility
• Cancer therapies
• Sustainability
• Strategic acquisitions
• Medical research
• Community engagement
• Medicines portfolio
• Innovative medicines
• B2B
• HIV/AIDS treatments
• Health equity
• Patient access
• Emerging viruses
• Global market
• Viral hepatitis treatments
• Healthcare providers
• Patient safety
• Research funding
• Research and development
• Single-tablet regimens
• Biopharmaceutical
• Global health
• Drug pricing strategies
• Long-acting therapies
• CAR-T cell therapy
• Antiviral therapies
• Oncology
• Viral disease management
• HIV treatments
• Hepatitis C treatments
• Oncology drugs
• HCV cure
• Clinical pipeline
• Patient care
• HIV pre-exposure prophylaxis
• Healthcare access in LMICs
• Public health initiatives
• Respiratory conditions
• Clinical trials
• Community-based research
• Drug development
• Therapeutic pipeline
• Inflammation therapies
• Pharmaceuticals
• Services
• Virology
• Inflammation
• HIV
• Viral hepatitis
• COVID-19
• Antiviral treatments
• Pharmaceutical development
• Medications
• Chronic inflammation treatments
• Public health
• Transformative therapies
• Long-acting treatment
• Pre-exposure prophylaxis
• Hepatitis cure
• Diversity in clinical trials
• Global health access
• Corporate giving
• Employee resource groups
• Consumer health data privacy
• Anti-counterfeiting
• Authorized distributors
• U.S. patient access
• Research collaborations
• Innovation in healthcare
• Global workforce
• Clinical research programs
• Science and technology
• Employee inclusion
• Research publications
• Adverse event reporting
• Strategic initiatives
• Community outreach
• Health education programs
• Global operations
• Pipeline management
• Clinical development
• Social impact
• Health disparities
• Non-profit
• Manufacturing
• Distribution
• Enterprises
• Computer software
• Information technology & services
• Health, wellness & fitness
• Environmental services
• Renewables & environment
• Research & development
• Hospital & health care
• Medical
• Nonprofit organization management
• Mechanical or industrial engineering

Technologies Used

• AI
• ASP.NET
• Adobe Media Optimizer
• Apache
• Backbone JS Library
• Bootstrap Framework
• CSC Corporate Domains
• Cedexis Radar
• Citrix
• CloudFlare CDN
• CloudFlare Hosting
• Data Analytics
• DotNetNuke
• DoubleClick Floodlight
• Drupal
• Google Analytics
• Google Font API
• Google Tag Manager
• Google translate API
• Google translate widget
• Marketo
• Microsoft Azure Hosting
• Microsoft Office 365
• Mimecast
• Mobile Friendly
• Multilingual
• OneTrust
• Outlook
• React Redux
• Remote
• Ruxit
• SiteCore
• Typekit
• Vimeo
• Workday Recruit
• YouTube
• reCAPTCHA

Affiliated Organizations & Regional Branches

• Arresto BioSciences
• Kite Pharma
• Immunomedics
• Gilead Sciences China
• Nimbus Therapeutics
• Tmunity Therapeutics Incorporated
• Calistoga Pharmaceuticals
• Cell Design Labs, Inc.
• Kite Medical
• XinThera, LLC
• MiroBio Ltd
• CymaBay Therapeutics
• CV Therapeutics
• Gilead Sciences Italia
• ギリアド・サイエンシ・株
• DE-GILEAD MEDICAL SERVICES
• Tmunity Therapeutics, Inc.
• CGI Pharmaceuticals, Inc.
• EpiTherapeutics ApS
• YM BioSciences
• Change Pharma
• Gilead Sciences Nordics
• MYR Pharmaceuticals